In the Mix: 13 More Articles — June 26, 2026
June 26, 2026. 13 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score.
Using Cannabis Could Raise Your Stroke Risk by 37%, Massive Study Reveals
A large study suggests potential association between cannabis use and increased stroke risk, which merits awareness for clinicians evaluating cardiovascular health in patients.
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →D.C. Council to Hold Public Hearing Next Week on Four Medical Cannabis Bills
The District of Columbia Council will discuss proposed legislation regarding medical cannabis, potentially impacting access and product regulations relevant to clinicians practicing in the area.
Read more →Meet the Veteran Who Earns Thousands by Harvesting a Common Weed – Exploding Topics
The article details an individual’s income from cultivating cannabis, specifically mentioning THCV, which may be relevant due to emerging research into minor cannabinoid effects.
Read more →Madison police detail investigation into how marijuana trafficking sparked violent crime spree
This article details a police investigation linking illegally trafficked cannabis to subsequent violent crime, potentially informing clinicians about associated public safety concerns.
Read more →Mass. cannabis industry ramps up fight against repealing pot – Axios Boston
The article details an effort to repeal Massachusetts’ adult-use cannabis law, which clinicians should note as potential regulatory changes impact patient access.
Read more →SEC drops case as cannabis company turns over new leaf – ICLG
This article details the resolution of a Securities and Exchange Commission case involving Grown Rogue International following a corporate restructuring, which may reflect industry-wide financial trends.
Read more →Bringing Care to Members Where They Are in Los Angeles and San Diego Counties
This article details healthcare access initiatives for Blue Shield Promise members in California, potentially relevant as social determinants of health impact patient care and outcomes.
Read more →AGIBOT Brings APC 2026 to Thailand, Building a Professional Partner Ecosystem to …
This article details a technology partnership event in Thailand potentially relevant as the country expands its legal framework for cannabis products and services.
Read more →Chinese robotics firm lands key partnership in Thailand-Xinhua
This news reports a partnership between Chinese robotics firm AgiBot and a Thai ICT distributor, potentially relevant as automation impacts cultivation or dispensary technologies.
Read more →Sixteen arrested after nine cannabis factories uncovered across the North – Roscommon Herald
This article reports on law enforcement actions against illegal cannabis cultivation operations in Ireland, potentially indicating trends in illicit production methods or geographic areas of concern.
Read more →2 Norwalk vape shops busted selling marijuana without license, police say | fox61.com
Norwalk police reported seizing unlicensed marijuana products and nitrous oxide from a convenience store, which may be relevant for tracking illicit market activity.
Read more →Prison term in abduction of Peekskill man over stolen marijuana money – The Journal News
This article details a criminal case involving financial disputes within the illicit cannabis market, potentially highlighting security risks for those involved in unregulated transactions.
Read more →Why Did (TSX:ACB) Reach New Revenue Highs in FY2026? | Kalkine Media
This article details Aurora Cannabis’s financial performance in fiscal year 2026, potentially informing clinicians about market trends and the expansion of European medical cannabis access.
Read more →Digest-Level Clinical Commentary
These headlines reflect a field in tension between legitimate medical advancement and significant public health concerns that complicate clinical practice. While item 13 signals growing legitimacy through mainstream business success and item 2 indicates policy evolution toward medical access, items 1, 4, 10, 11, and 12 underscore that cannabis remains entangled with serious adverse health outcomes, criminal activity, and regulatory chaos that make evidence-based prescribing challenging. As a practitioner, I must acknowledge that the stroke risk signal in item 1, if validated, represents exactly the kind of harm data that should inform patient counseling, even as I recognize cannabis has genuine therapeutic applications where benefits may outweigh documented risks.
These items reflect the ongoing tension between cannabis’s emerging medical applications and the public health and criminal justice challenges associated with its widespread availability. The coverage spans legitimate clinical interests, such as stroke risk and regulatory frameworks for medical cannabis, alongside significant enforcement issues related to illegal cultivation and trafficking. Clinicians should note that while some cannabis compounds show potential therapeutic value, the market’s rapid expansion has outpaced robust safety data and created substantial criminal activity that affects community health.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
